[Aichi Prefecture, Nishio City] "Metallo-Balance Test" to Assess Cancer and Cognitive Decline Risk with Just 6mL Blood Draw to Begin at Yamagishi Clinic from August 2026 <Reservations Now Open>

Renatech Inc. (Headquarters: Isehara City, Kanagawa Prefecture), which builds health indicators based on trace elements and applies them in real-world settings, is pleased to announce that its screening test, the "Metallo-Balance Test," developed and provided by the company to assess the risk of cancer and MCI (Mild Cognitive Impairment), will newly commence at Yamagishi Clinic (Nishio City, Aichi Prefecture) starting August 24, 2026 (Mon).

With the addition of this clinic, the examination system for the "Metallo-Balance Test" in the Nishio City, Aichi Prefecture area will be further expanded, offering a more accessible and new health management option to the local community.

Our company will continue to partner with medical institutions nationwide to encourage more people to take an interest in their health status and provide an opportunity to review their daily health management and lifestyle habits as a measure against pre-illness conditions.

What is the Metallo-Balance (MB) Test?

This is a risk screening (sorting) test that objectively assesses the risk of cancer and MCI (Mild Cognitive Impairment) at the time of blood collection by analyzing the concentration balance of 17 types of trace elements (metal elements) in the blood.

【Features of this Test】

Just one 6mL blood draw: Blood is collected safely under appropriate management systems at a medical institution. The test takes approximately 15 minutes, is short, and has minimal physical burden, providing peace of mind.

Site-specific "Cancer Risk Test": With a single blood draw, the risk of the following cancers is assessed by site (6 sites for men, 9 sites for women) and scored on a 4-point scale from A to D. [Men] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, prostate cancer [Women] Lung cancer, stomach cancer, liver cancer, pancreatic cancer, colorectal cancer, breast cancer, cervical cancer, uterine body cancer, ovarian cancer

Comprehensive "Cognitive Risk Test (MCI Risk Assessment)": This test comprehensively assesses all types of cognitive decline, not just Alzheimer's type, but also vascular and Lewy body types.

Proven Research Track Record and International Recognition: Developed with research grants from the Ministry of Economy, Trade and Industry's Go-Tech project and through joint research with the Kanagawa Cancer Center and Chiba Cancer Center. Patents have been obtained in 9 countries worldwide, including Japan, and the cumulative number of examinees has surpassed 100,000 (results from April 2019 to March 2026).

Examination Flow and Main Precautions Before Examination

※ Due to the need for mail-in procedures, advance application is required approximately 3 weeks before the desired examination date (fully reservation-based).

Application: Please apply via the web or by phone. Approximately one week before your reservation date, a complete set of examination documents will be delivered to your home.

Day of Examination (Blood Collection): As it is fully reservation-based, blood collection will proceed smoothly (approx. 15 minutes). Payment is post-paid, so no payment is required at the counter on the day.

Result Notification: The invoice (payment slip) will be mailed to your home approximately 3 weeks after blood collection, and the test results will be mailed approximately 5 weeks later.

【Main Precautions Before Examination】

Food and Drink: No food or drink after 9:00 PM the day before. No alcohol from the day before. Water: Please drink plenty of water to facilitate blood collection.

Medications and Supplements: No over-the-counter medications or supplements from the day before. Continue taking prescribed medications as usual.

Examination Fees (Out-of-Pocket Medical Expenses)

This test is not covered by health insurance and is considered out-of-pocket medical expenses. You can choose from the following courses according to your needs.

Cancer Risk Test: ¥19,800 (tax included)

Cognitive Risk Test: ¥19,800 (tax included)

Cancer and Cognitive Risk Test Set: ¥24,200 (tax included)

※ Prices shown are standard prices. ※ Payment will be made via "DSK Post-Payment" delivered to your home after blood collection. ※ Some medical institutions may not offer one of these tests.

Target Individuals and Precautions for the Metallo-Balance Test

【Regarding Target Age】

Cancer Risk Test: Japanese individuals aged 20 to 80

Cognitive Risk Test: Japanese individuals aged 50 to 80

※ As this test was developed based on data from Japanese individuals within the above age ranges, individuals outside these age ranges or foreign nationals can still undergo the test, but the results will be considered "reference values" only. Please be aware of this in advance.

【Individuals who cannot undergo the test】

Pregnant women or those within 6 months postpartum

Individuals undergoing cancer treatment or those who have completed cancer treatment less than 1 year ago

Individuals undergoing dialysis

Individuals with fractures, blood disorders, or immunodeficiency (※excluding dyslipidemia due to high triglycerides, etc.)

Individuals in poor health (lack of sleep, after staying up all night, immediately after strenuous exercise, under severe stress, or with symptoms such as colds, asthma, shingles, allergic rash/rhinitis, etc.)

Overview of New Introducing Medical Institution

Test Start Date: August 24, 2026 (Mon) Examination Hours: Generally Monday to Saturday (excluding holidays and public holidays)

Medical Institution Name: Yamagishi Clinic

Address: 1-55 Nagayoshi, Nishio City, Aichi Prefecture, 445-0870 📍MAP

Access: ● Train: 13-minute walk from Nishio Station on the Meitetsu Nishio Line

Tests Offered: Cancer Risk Test, Cognitive Risk Test

⚠️ Important Request Regarding Examinations (Please Read Carefully) Refrain from direct contact with the medical institution: The hospital counter and phone lines cannot handle inquiries or applications for this test. Please contact Renatech for any questions or applications regarding the test.

For details and applications about the test, click here

Metallo-Balance Test Information Site: https://www.mbkensa.com/

Dedicated Toll-Free Number: 0120-785-602 (Renatech: Weekdays 9:00 AM - 5:00 PM)

▼ Digital Brochure of Metallo-Balance Test

d182526-17-68cee466c7c834b23fde26e5538bbab7.pdf

🏥 Partner Medical Institutions Wanted Nationwide! Click here for information on introducing the Metallo-Balance Test

Metallo-Balance Original Character: Metarona-chan

Renatech Inc. is an innovation company that develops unique technologies in the medical and health fields, as well as the environmental field, aiming for early risk assessment of diseases such as cancer. It has also been selected as one of the "300 Brilliant Companies of SMEs/Small Businesses that Shine" by the Ministry of Economy, Trade and Industry and the Small and Medium Enterprise Agency, recognizing outstanding companies that provide innovative technological development and services, acknowledging its high technological capabilities and social contribution at the national level.

Among these, the "Metallo-Balance Test" is attracting significant attention as a groundbreaking screening technology that assesses the risk of developing cancer and MCI (Mild Cognitive Impairment) by analyzing the concentration of 17 types of trace elements in the blood. Moving forward, based on its advanced technological capabilities, the company will continue to create new value for the promotion of people's health and the resolution of social issues.

Company Profile ■

Company Name: Renatech Inc.

Representative: Kei Kato, Representative Director

Head Office Location: 4-19-15 Takamori, Isehara City, Kanagawa Prefecture, 259-1114

URL: https://www.renatech.net/